| Literature DB >> 31756911 |
Khov Kuong1,2, Pety Tor3, Marlene Perignon4, Marion Fiorentino4, Chhoun Chamnan1, Jacques Berger4, Kurt Burja5, Marjoleine A Dijkhuizen2, Megan Parker6, Nanna Roos2, Frank T Wieringa4.
Abstract
BACKGROUND: Within Cambodia, micronutrient deficiencies continue to be prevalent in vulnerable groups, such as women and children. Fortification of staple foods such as rice could be a promising strategy for Cambodia to improve micronutrient status.Entities:
Keywords: Cambodia; deficiency; fortified rice; micronutrient; school children; zinc
Mesh:
Substances:
Year: 2019 PMID: 31756911 PMCID: PMC6949998 DOI: 10.3390/nu11122843
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Micronutrient contents of normal rice, and the actual and target values of the different types of fortified rice, per 100g of uncooked blended rice.
| Micronutrients | Normal Rice 1 | URO | URN | NutriRice | Target Value |
|---|---|---|---|---|---|
| Iron (mg) | 0.3 | 10.67 | 7.55 | 7.46 | 7.26 |
| Zinc (mg) | 1.0 | 3.04 | 2.02 | 3.68 | 3.50 |
| Vitamin B1 (mg) | ND | 1.06 | 1.43 | 0.69 | 0.60 |
| Folic Acid (mg) | ND | 0.17 | 0.28 | 0.14 | 0.20 |
| Vitamin A (mg) | 0.03 | - | 0.64 | 0.29 | 0.30 |
| Vitamin B3 (mg) | ND | - | 12.57 | 7.98 | 8.00 |
| Vitamin B12 (μg) | 0.4 | - | 3.8 | 1.3 | 1.2 |
| Vitamin B6 (mg) | 0.1 | - | - | 0.92 | 0.65 |
Abbreviations: URO: UltraRice original formula, URN: UltraRice new formula, ND: no data. 1 Composition of normal rice based on the analyses of 10 rice samples.
Figure 1Flow chart of the study.
Baseline characteristics of children in the study.
| Outcomes | Placebo | URO | URN | NutriRice |
|---|---|---|---|---|
|
| 462 | 453 | 468 | 475 |
| Age (y) | 9.62 ± 2.29 | 9.63 ± 2.18 | 9.61 ± 2.20 | 9.73 ± 2.42 |
| % girls | 50.2 ( | 49.4 ( | 50.0 ( | 49.9 ( |
| % inflammations | 42.9 ( | 42.4 ( | 32.5 ( | 32.2 ( |
| % parasite infection | 22.9 ( | 25.8 ( | 19.8 ( | 12.9 ( |
| % Hemoglobinopathy | 41.8 ( | 43.9 ( | 43.4 ( | 41.7 ( |
|
| ||||
| Underweight (WAZ ≤2) | 43.1% ( | 40.1% ( | 49.6% ( | 40.1% ( |
| Stunted (HAZ ≤2) | 43.8% ( | 39.6% ( | 44.5% ( | 45.5% ( |
| Wasted (BAZ ≤2) | 25.4% ( | 27.0% ( | 29.8% ( | 21.5% ( |
|
| ||||
| Hb (g/L) | 123.5 ± 10.2 | 124.2 ± 9.8 | 123.7 ± 9.2 | 123.9 ± 10.4 |
| % anemia | 18.7 ( | 15.3 ( | 17.5 ( | 17.2 ( |
| ID total | 55.2 ( | 56.8 ( | 48.6 ( | 49.0 ( |
| ID with anemia | 11.9 ( | 10.2 ( | 10.5 ( | 10.3 ( |
| Body Iron (mg/kg) | 6.49 ± 2.0 | 6.53 ± 2.2 | 6.16 ± 2.4 | 6.16 ± 2.4 |
| % 0 < BI < 4 mg/kg | 9.0 ( | 10.9 ( | 11.6 ( | 13.3 ( |
| % BI < 0 mg/kg | 1.3 ( | 1.3 ( | 3.0 ( | 2.6 ( |
| RBP (µmol/L) | 1.62 ± 0.43 | 1.68 ± 0.43 | 1.48 ± 0.43 | 1.51 ± 0.43 |
| % marginal VA status | 7.5 ( | 3.8 ( | 13.8 ( | 12.4 ( |
| % VAD | 0.7 ( | 0.2 ( | 1.3 ( | 1.1 ( |
| Serum Zinc (µmol/L) | 7.7 ± 1.86 | 7.74 ± 1.69 | 7.61 ± 1.70 | 8.11 ± 1.88 |
| % zinc deficiency | 89.4 ( | 90.1 ( | 92.3 ( | 83.6 ( |
| % Severe zinc deficiency (<7.6 µmol/L) | 49.8 ( | 49.7 ( | 53.8 ( | 43.6 ( |
| Serum Folate (ng/mL) | 5.40 ± 1.60 | N/A | N/A | 6.25 ± 2.06 |
| % Folate deficiency | 18.0 | N/A | N/A | 9.1 |
Results are mean ± SD unless stated, WAZ: Weight-for-age-z-scores, HAZ: height-for-age z-scores, BAZ: BMI-for-age-z-scores, Hb: hemoglobin, ID: Iron deficiency, BI: body iron, RBP: Retinol Binding Protein, VA: Vitamin A, VAD: Vitamin A deficiency, N/A: not available, URO: UltraRice original formula, URN: UltraRice new formula.
Dietary information and attendance of each intervention group.
| Variables | Placebo | URO | URN | NutriRice |
|---|---|---|---|---|
|
| ||||
|
| 462 | 453 | 468 | 475 |
| Number of school days over the whole study period | 127 | 126 | 126 | 132 |
| % of attendance over the study period | 86.6% | 82.0% | 83.6% | 84.1% |
| Number school days in the BL–ML period | 75 | 81 | 82 | 86 |
| % attendance over the BL–ML period | 88.5% | 85.0% | 87.7% | 87.2% |
| Number of school days in the ML–EL period | 68 | 61 | 62 | 52 |
| % attendance over the ML–EL period | 87.6% | 88.4% | 87.7% | 86.5% |
| % attendance within 10 days before ML | 89.9% | 87.7% | 88.4% | 87.0% |
| % attendance within 10 days before EL | 86.3% | 86.5% | 87.8% | 85.7% |
|
| ||||
| Zinc in fortified rice, mg/100g | - | 3.0 | 2.0 | 3.7 |
| Estimated zinc intake at school meal (%RDA)* | - | 3.5 (44%) | 2.3 (29%) | 4.2 (53%) |
| Estimated zinc intake per child from BL–EL, mg | - | 441.0 | 292.3 | 558.4 |
| Estimated zinc intake per child from BL–ML, mg | - | 283.5 | 190.2 | 363.8 |
| Estimated zinc intake per child from ML–EL, mg | - | 213.5 | 143.8 | 219.9 |
|
| ||||
| Phytate content, mg/100g of cooked rice | 108.9 | 108.9 | 108.9 | 108.9 |
| Phytate:zinc molar ratio | - | 3.55 | 5.34 | 2.93 |
|
| ||||
| N | 50 | 88 | ||
| Folic acid in fortified rice, mg/100g | - | 0.17 | 0.28 | 0.14 |
| Estimated folic acid intake per meal (% RDA)* | - | 0.2 (50%) | 0.32 (80%) | 0.16 (40%) |
| Estimated folic acid intake per child from BL-EL, mg | - | 25.4 | 35.3 | 21.1 |
* meal ratio corresponding to 115 g uncooked rice. BL: Baseline, ML: Midline, EL: Endline, RDA: Recommended daily allowance, URO: UltraRice original formula, URN: UltraRice new formula.
Biochemical outcomes of serum zinc concentration of participating children after three and six months of intervention.
| Time Point | Group |
| Mean | SE | Estimated Effect | |
|---|---|---|---|---|---|---|
| Baseline | Placebo | 462 | 7.83 | 0.08 | - | |
| URO | 453 | 7.83 | 0.08 | - | ||
| URN | 468 | 7.67 | 0.08 | - | ||
| NutriRice | 475 | 8.15 | 0.08 | - | ||
| Midline | Placebo | 393 | 9.71 | 0.09 | - | |
| URO | 389 | 8.69 | 0.09 | −1.02 (−1.43; −0.61) | <0.001 | |
| URN | 389 | 9.72 | 0.09 | −0.17 (−0.24; 0.58) | 0.422 | |
| NutriRice | 351 | 9.54 | 1.00 | −0.50 (−0.93; 0.07) | 0.024 | |
| Endline | Placebo | 401 | 7.57 | 0.09 | - | |
| URO | 418 | 8.56 | 0.09 | 0.98 (0.58; 1.38) | <0.001 | |
| URN | 428 | 8.27 | 0.09 | 0.85 (0.45; 1.25) | <0.001 | |
| NutriRice | 420 | 9.29 | 0.09 | 1.40 (0.98; 1.82) | <0.001 |
1 Interaction term of Group x time (GLM mixed model adjusted for age, gender, hemoglobinopathy, body iron. Hb concentration, anaemia parasiste infection, and inflammation); URO: UltraRice original, URN: UltraRice new, SE: Standard Error of the mean, CI: confidence interval.
Prevalence of zinc deficiency of participating children after three and six months of interventic.
| Zinc Deficiency | Severe Zinc Deficiency | |||||||
|---|---|---|---|---|---|---|---|---|
| (<9.9 µmol/L) | (<7.6 µmol/L) | |||||||
| Time Point Group |
| Estimated Effect | Estimated Effect | |||||
| % | Adjusted OR1 | % | Adjusted OR1 | |||||
| (95% CI) | (95% CI) | |||||||
| Placebo | 462 | 89.4 | - | 49.8 | - | |||
| URO | 453 | 90.1 | - | 49.7 | - | |||
| Baseline | URN | 468 | 92.3 | - | 53.8 | - | ||
| NutriRice | 475 | 83.6 | - | 43.6 | - | |||
| Placebo | 393 | 60.6 | - | 15.5 | - | |||
| URO | 389 | 79.2 | 2.25(1.23;4.10) | 0.08 | 22.4 | 1.56(0.93;2.62) | 0.09 | |
| Midline | URN | 389 | 55.8 | 0.05(0.30;1.02) | 0.059 | 15.4 | 0.79(0.46;1.37) | 0.4 |
| NutriRice | 351 | 60.1 | 1.25(0.69;2.26) | 0.461 | 17.7 | 1.36(0.76;2.42) | 0.29 | |
| Placebo | 401 | 93.3 | - | 53.6 | - | |||
| URO | 418 | 80.6 | 0.25(0.12;0.52) | <0.001 | 29.7 | 0.35(0.22;0.55) | <0.001 | |
| Endline | URN | 428 | 83.4 | 0.25(0.11;0.53) | <0.001 | 37.1 | 0.39(0.25;0.60) | <0.001 |
| NutriRice | 420 | 65.7 | 0.16(0.08;0.34) | <0.001 | 25.7 | 0.28(0.17;0.47) | <0.001 | |
1 Interaction term of Group x time (GLM mixed model adjusted for age, gender, hemoglobinapathy, bodyiron, Hb concentration, anaemia, parasiste infection and inflammation.
Biochemical outcomes of folate concentration and deficiency of participating children.
| Biochemical Indicator | Placebo | Nutririce |
|---|---|---|
| Serum Concentration | ||
|
| 50 | 88 |
| Baseline (± SD), ng/mL | 5.40 ± 1.60 | 6.25 ± 2.06 |
| Endline (± SD), ng/mL | 7.13 ± 1.70 | 9.54 ± 2.76 |
| Coefficient 1 (95% CI) | - | 2.25 * (0.63; 3.87) |
| Deficiency Prevalence | ||
|
| 50 | 88 |
| Baseline (%) | 18.0% | 9.1% |
| Endline (%) | 2.0% | 0% |
| Adjusted OR 1 (95% CI) | - | 1.59 (0.11; 23.47) |
1 Interaction term of Group x time (GLM mixed model adjusted for age, gender, hemoglobinopathy, body iron, Hb concentration, anaemia, parasiste infection, and inflammation). * Siginificant difference of group at endline compared to baseline. SD: Standard Deviation, OR: Odds Ratio, CI: Confidence interval.